An emerging generation of endocrine therapies in breast cancer: a clinical perspective

Epigenetics - Wikipedia

PDF) An emerging generation of endocrine therapies in breast

Inclusion and exclusion criteria.

PDF] Neoadjuvant endocrine therapy for luminal breast cancer treatment: a first-choice alternative in times of crisis such as the COVID-19 pandemic

Chemotherapy and Targeted Therapy for Endocrine-Pretreated or Hormone Receptor–Negative Metastatic Breast Cancer: ASCO Guideline Rapid Recommendation Update

Circulating tumor DNA validity and potential uses in metastatic

Advancements in clinical aspects of targeted therapy and immunotherapy in breast cancer, Molecular Cancer

Precision oncology: a clinical and patient perspective - Oncology

Efficacy of select single agent anti-estrogen therapies in phase I

ZB716, a steroidal selective estrogen receptor degrader (SERD), is

Cancers, Free Full-Text

EMJ Oncology 11.1 2023 by European Medical Journal - Issuu